2007
DOI: 10.1016/j.ijrobp.2007.07.261
|View full text |Cite
|
Sign up to set email alerts
|

A Dosimetric Comparison of MammoSite™ and ClearPath™ HDR Breast Brachytherapy Devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The authors of this study found that the two devices offered comparable target volume coverage, but that CP allowed signifi cantly more normal tissue sparing. The mean ipsilateral breast V50 was 19.8% vs. 18.0%, the mean ipsilateral lung V30 was 3.7% vs. 2.8%, the mean heart V5 was 57.0% vs. 54.3%, and the maximum skin point doses per fraction were 312.2 and 273.6 cGy for the MS and CP methods respectively (Dickler 2007). …”
Section: Supporting Datamentioning
confidence: 95%
“…The authors of this study found that the two devices offered comparable target volume coverage, but that CP allowed signifi cantly more normal tissue sparing. The mean ipsilateral breast V50 was 19.8% vs. 18.0%, the mean ipsilateral lung V30 was 3.7% vs. 2.8%, the mean heart V5 was 57.0% vs. 54.3%, and the maximum skin point doses per fraction were 312.2 and 273.6 cGy for the MS and CP methods respectively (Dickler 2007). …”
Section: Supporting Datamentioning
confidence: 95%